3rd National Hepatitis Symposium 2018

1-2 March 2018
Kuala Lumpur, Malaysia
Jean Michel Piedagenel, Head of DNDi South East Asia Regional Office, Malaysia – panel discussion on access to hepatitis treatment
François Simon, Clinial Trial Leader Paediatric HIV/HCV, DNDi, Switzerland – expert talk on clinical trials

GHIT R&D Forum

December 8, 2017
Tokyo, Japan
DNDi presented at the event on the NTD Drug Discovery Booster, Chagas disease, and mycetoma.

The challenge of conducting clinical trials in remote and conflict areas

The journey to the sleeping sickness trial site in Isangi from the DNDi office in Kinshasa begins in the domestic airport of DRC’s capital city and ends more than a day later halfway across the country in a barge crossing the Congo river. In between: hours spent navigating potholed dirt roads, collapsed bridges, checkpoints, and multiple river crossings. Once at Isangi, canoes must be used to reach many of the patients as there are no roads.

Yet for DNDi’s clinical team in DRC, Isangi is one of the easier-to-reach sites. The DRC and the Central African Republic (CAR) both pose daunting challenges that must be overcome to develop better treatments for patients suffering from sleeping sickness.